UPEXI, INC.
Datakwaliteit: 100%
UPXI
Nasdaq
Financial Services
Nondepository Credit Institutions
€ 1,10
▲
€ 0,06
(5,77%)
Marktkapitalisatie: 71,42 M
Prijs
€ 1,03
Marktkapitalisatie
71,42 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Revenue declined -10,00% annually over 5 years
Negative free cash flow of -17,78 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 29,19%
Capital efficient — spends only 1,02% of revenue on capex
Groei
Revenue Growth (5Y)
-10,00%
Onder sectorgemiddelde (5,90%)
Revenue (1Y)-39,19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-94,74%
Onder sectorgemiddelde (9,24%)
ROIC-27,80%
Net Margin-496,88%
Op. Margin-470,07%
Veiligheid
Debt / Equity
1,29
Boven sectorgemiddelde (0,49)
Current Ratio2,20
Interest Coverage-175,93
Waardering
PE (TTM)
-0,58
Onder sectorgemiddelde (11,15)
P/B Ratio1,47
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Financial Services sector mediaan (2180 peers)
Sectorvergelijking
vs Financial Services sector mediaan (2180 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,6 | 11,1 |
| P/B | 1,5 | 1,2 |
| ROE % | -94,7 | 9,2 |
| Net Margin % | -496,9 | 9,4 |
| Rev Growth 5Y % | -10,0 | 5,9 |
| D/E | 1,3 | 0,5 |
Koersdoel Analisten
2 analisten
Buy
Huidig
€ 1,10
Koersdoel
€ 5,00
€ 2,00
€ 5,00
€ 8,00
Vooruitzicht
Forward K/W
-3,86
Forward WPA
-€ 0,29
Omzet Sch.
33,63 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
-€ 0,29
-€ 0,51 – -€ 0,06
|
33,63 M | 2 |
| FY2026 |
-€ 1,94
-€ 1,94 – -€ 1,94
|
29,80 M | 1 |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 |
-€ 0,19
-€ 0,19 – -€ 0,19
|
6,40 M | 1 |
| 2026 Q1 |
-€ 0,20
-€ 0,20 – -€ 0,20
|
6,10 M | 1 |
Winstverassingen
Laatste 5 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | -€ 0,08 | -€ 0,21 | -177,6% |
| Q32025 | -€ 0,01 | -€ 0,13 | -1171,0% |
| Q22025 | -€ 0,07 | N/A | — |
| 2026-Q1 | -€ 0,20 | € 0,76 | +480,0% |
| Q12025 | N/A | -€ 2,87 | — |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -39,19% | Revenue Growth (3Y) | -55,73% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -10,00% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 24,74 M | Net Income (TTM) | -122,93 M |
| ROE | -94,74% | ROA | -35,59% |
| Gross Margin | 80,67% | Operating Margin | -470,07% |
| Net Margin | -496,88% | Free Cash Flow (TTM) | -17,78 M |
| ROIC | -27,80% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,29 | Current Ratio | 2,20 |
| Interest Coverage | -175,93 | Asset Turnover | 0,07 |
| Working Capital | 93,40 M | Tangible Book Value | 47,17 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,58 | Forward P/E | N/A |
| P/B Ratio | 1,47 | P/S Ratio | 2,89 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -24,89% | ||
| Market Cap | 71,42 M | Enterprise Value | 134,12 M |
| Per Share | |||
| EPS (Diluted TTM) | 1,83 | Revenue / Share | 0,36 |
| FCF / Share | -0,26 | OCF / Share | -0,25 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 1,02% | FCF Conversion | 14,46% |
| SBC-Adj. FCF | -32,50 M | Growth Momentum | -29,19 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 15,81 M | 26,00 M | 80,68 M | 44,58 M | 24,10 M |
| Net Income | -13,68 M | -23,66 M | -17,49 M | -2,05 M | 2,98 M |
| EPS (Diluted) | -1,73 | -23,03 | -0,96 | -0,13 | 0,21 |
| Gross Profit | 10,87 M | 12,82 M | 33,56 M | 25,19 M | 11,90 M |
| Operating Income | -12,50 M | -22,46 M | -7,55 M | -2,65 M | 1,43 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 757.758,0 | 3,68 M | 5,15 M | 2,73 M | 1,03 M |
| Interest Expense | 103.805,0 | -3,12 M | -4,76 M | 38.290,0 | 13.946,0 |
| Income Tax | 0,0 | 332.101,0 | 3,05 M | 518.398,0 | 1,28 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 123,81 M | 23,51 M | 63,85 M | 48,49 M | 27,25 M |
| Total Liabilities | — | — | — | — | — |
| Shareholders' Equity | 90,10 M | 6,52 M | 27,84 M | 28,79 M | 21,22 M |
| Total Debt | 20,00 M | — | 27,75 M | — | — |
| Cash & Equivalents | — | — | — | 7,15 M | 14,53 M |
| Current Assets | 56,78 M | 11,42 M | 25,46 M | 17,06 M | 18,29 M |
| Current Liabilities | 32,56 M | 12,66 M | 19,61 M | 10,13 M | 5,82 M |
{"event":"ticker_viewed","properties":{"ticker":"UPXI","listing_kind":"stock","pathname":"/stocks/upxi","exchange":"Nasdaq","country":"US"}}